Patents by Inventor Andrew Curtis KRUSE

Andrew Curtis KRUSE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SIRP-gamma polypeptide compositions and treatment of cancer
    Patent number: 11407801
    Abstract: Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: August 9, 2022
    Assignee: Ab Initio Biotherapeutics, Inc.
    Inventors: Aaron Michael Ring, Roy Louis Maute, Andrew Curtis Kruse, Aashish Manglik, Kenneth S. Lin
  • SIRP-gamma polypeptide compositions and methods of use
    Patent number: 10774125
    Abstract: Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: September 15, 2020
    Assignee: AB INITIO BIOTHERAPEUTICS, INC.
    Inventors: Aaron Michael Ring, Roy Louis Maute, Andrew Curtis Kruse, Aashish Manglik, Kenneth S. Lin
  • SIRP POLYPEPTIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20200270324
    Abstract: Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.
    Type: Application
    Filed: May 4, 2020
    Publication date: August 27, 2020
    Inventors: Aaron Michael RING, Roy Louis MAUTE, Andrew Curtis KRUSE, Aashish MANGLIK, Kenneth S. LIN
  • METHODS OF TREATMENT FOR CANCER, STEROL HOMEOSTASIS, AND NEUROLOGICAL DISEASES
    Publication number: 20200000822
    Abstract: The present disclosure provides methods of treating cancer, sterol homeostasis diseases, and neurological diseases using compounds which modulate the activity of sigma receptors. In particular, the present disclosure provides method s of modulating the sigma 2 receptor for use in treating one or more diseases associated with that sigma receptor.
    Type: Application
    Filed: February 23, 2018
    Publication date: January 2, 2020
    Inventors: Andrew Curtis KRUSE, Assaf ALON, Hayden R. SCHMIDT, Stephen MARTIN, James SAHN, Michael WOOD
  • SIRP POLYPEPTIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20180155405
    Abstract: Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.
    Type: Application
    Filed: November 15, 2017
    Publication date: June 7, 2018
    Inventors: Aaron Michael RING, Roy Louis MAUTE, Andrew Curtis KRUSE, Aashish MANGLIK, Kenneth S. LIN
  • SIRP polypeptide compositions and methods of use
    Patent number: 9845345
    Abstract: Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: December 19, 2017
    Assignee: AB INITIO BIOTHERAPEUTICS, INC.
    Inventors: Aaron Michael Ring, Roy Louis Maute, Andrew Curtis Kruse, Aashish Manglik, Kenneth S. Lin
  • SIRP POLYPEPTIDE COMPOSITIONS AND METHODS OF USE
    Publication number: 20160340397
    Abstract: Provided herein are SIRP-gamma, SIRP-beta or SIRP-beta2 decoy polypeptides for immunotherapy and/or treatment of cancer, anemia, transplant, asthma, allergy, auto-immune disease, and viral infection.
    Type: Application
    Filed: May 17, 2016
    Publication date: November 24, 2016
    Inventors: Aaron Michael RING, Roy Louis MAUTE, Andrew Curtis KRUSE, Aashish MANGLIK, Kenneth S. LIN